Modified polycyclic compounds rescue mis-splicing in myotonic dystrophy type 1 myotubes
This study aimed at understanding the global transcriptomic effects of Modified polycyclic compounds, a new class of small molecules, on alternative splicing and differential gene expression in myotubes from myotonic dystrophy type 1 patients and unaffected individuals.